参考文献
[1]XUAN Y, YANG H, ZHAO L, et al. MicroRNAs in colorectal cancer: Small molecules with big Iunctions[J]. Cancer Letters, 2015, 360(2): 89.
[2]C’ARTHEW R W, SONTHEIMER E J. Origins and Mechanisms of miRNAs and siRNAs[J]. Ce11, 2009, 136(4): 642.
[3]FILIPOWICZ W, JASKIEWICZ I, KOLB F A, et al. Post transcriptional gene silencing by siRNAs and miRNAs[J]. Curr Opin Struct Biol, 2005, 15(3): 331.
[4]LYTLE J R, YARIO T A, STEITZ J A. Target mRNAs are repressed as efficiently by microRNA-binding sites in the 5’ UTR as in the 3’UTR[J]. Proc Natl Acad Sci USA, 2007, 104(23): 9667.
[5]BIMONTE S, BARBIERI A, LEONGITO M, et al. The Role of miRNAs in the Regulation of Pancreatic Cancer Stem Cells[J]. Stem Cells Int, 2016, 83 (5): 268.
[6]REN A, DONG Y, TSOF H, et al. Detection of miRNA as NorrInvasive Biomarkers of Colorectal Cancer[J]. International Journal of Molecular Sciences, 2015, 16(2): 2810.
[7]WANG J, DLL Y, LIU X, et al. MicroRNAs as Regulator of Signaling Networks in Metastatic Colon Cancer[J]. BioMed Research International, 2015, 2015: 1.
[8]KELLEY R K, WANG U, VENOOK A P. Biomarker use in colorectal cancer therapy[J]. J Natl Compr Canc Netw, 2011, 9(11): 1293.
[9]ROTELLI M T, DI LENA M, CAVALLINI A, et al. Fecal microRNA profile in patients with colorectal carcinoma before and after curative surgery[J].Int J Colorectal Dis, 2015, 30(7): 891.
[10]YAU T O, WU C W, DONG Y, et al. MicroRNA-221 and microRNA18a identification in stool as potential biomarkers for the norrinvasive diagnosis of colorectal carcinoma[J]. Br J C'ancer, 2014, 111(9): 1765.
[11]UHANBARI R, MOSAKHANI N, et al. Decreased expression of fecal miR-4478 and miR-1295b-3p in early-stage colorectal cancer[J]. Cancer Biomark, 2015, 15(2): 189.
[12]ZHU Y, XU A, et al. Fecal miR-29a and miR-224 as the non- invasive biomarkers for colorectal cancer[J]. Cancer Biomark, 2016, 6 (2): 259.
[13]COME H, MANCEAU U, BLONS H, et al. MicroRNA and colorectal cancer[J]. Dig Liver Dis, 2012, 44(3): 19.
[14]UIRALDEZ M D, LOZANO J J, RAMIREZ U, et al. Circulating microRNAs as biomarkers of colorectal cancer; results from a genome-wide profiling and validation study[J]. Clin Uastroenterol Hepato1, 2013, LL(6): 681.
[15]SCHETTER A J, OkAYAMA H, HARRIS C C. The Role of MicroRNAs in Colorectal Cancer [J]. The Cancer Journal, 2012, 18(3): 244.
[16]AKAO Y, NAKAGAWA Y, HIRATA I, et al. Role of anti-oncomirs miR143 and -145 in human colorectal tumors[J]. Cancer Uene Ther, 2010, 17 (8): 398.
[17]林茂松. 人结直肠癌微小RNA表达谱及其临床意义的研究[D]. 苏州大学, 2010.
[18]ZHANG W, ZHANG T, JIN R, et al. MicroRNA-301a promotes migration and invasion by targeting TUFBR2 in human colorectal cancer[J]. Journal of Experimental & Clinical Cancer Research, 2014, 33(1): 28.
[19]AHMED F E, JEFIRIES C D, VOS P W, et al. Diagnostic microRNA markers for screening sporadic human colon cancer and active ulcerative colitis in stool and tissue[J]. Cancer Genomics Proteomics, 2009 , 6 (5) : 281.
[20]LAWRIE C H, UAI S, DUNLOP H M, et al. Detection of elevated levels of tumour- associated microRNAs in serum of patients with dilfuse large I3-cell lymphoma[J]. Br J Haematol, 2008, 141(5): 672.
[21]CHEN X, BA Y, MA L, et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases[J]. Cell Res, 2008, 18(10): 997.
[22]郭秀丽, 姚士伟, 朱东, 等. 外周血miRNA-17-3p的检测在结肠癌诊断中的临床意义[J]. 世界华人消化杂志, 2014(30): 4701.
[23]HUANG Z, HUANG D, NI S, et al. Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer[J]. IntJ Cancer, 2010, 127(1): 118.
[24]陈建梅. 血浆miRNA预测结肠癌远处转移和化疗耐药性研究[D]. 中南大学，2014.
[25]MO Z, WU X, et al. Expression and Clinical Significance of MicroRNA-376a in Colorectal C'ancer[J]. Asian Pacific Journal of Cancer Prevention, 2014, 15(21): 23.
[26]LUO X, BURWINKEL B, TAO S, et al. MicroRNA signatures: novel biomarker for colorectal cancer[J]. Cancer Epidemiol Biomarkers Prev, 2011, 20 (7): 1272.
[27]HUANG L, WANG X, WEN C, et al. Hsa-miR-19a is associated with lymph metastasis and mediates the TNF-a induced epithelial-to-mesenchymal transition in colorectal cancer[J]. Scientific Reports, 2015, 5: 13350.
[28]OBERG A I, FRENCH A J, SARVER A I, et al. miRNA expression in colon polyps provides evidence for a multihit model of colon cancer[J]. PloS One, 2011, 6(6): e20465.
[29]SCHETTER A J, LEUNG S Y, SOHN J J, et al. MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma[J]. JAMA, 2008, 299(4): 425.
[30]YAMAMICHI N, SHIMOMURA R, INADA K, et al. Locked nucleic acid in situ hybridization analysis of miR-21 expression during colorectal cancer development[J]. Clin Cancer Res, 2009, 15(12): 4009.
[31]MEDINA P P, NOLDE M, SLACK F J. OncomiR addiction in an in vivo model of microRNA-21-induced pre-I]cell lymphoma [J].Nature, 2010, 467(7311): 86.
[32]THORSTENSEN I, LIND U E, LOVIG T, et al. Uenetic and epigenetic changes of components affecting the WNT pathway in colorectal carcinomas stratified by microsatellite instability[J]. Neoplasia, 2005, 7(2): 99.
[33]NAGEL R, DIOSDADO B, et al. Regulation of the adenomatour polyposis coli gene by the miRNA family in colorectal cancer[J].Cancer Res, 2008, 68(14): 79.
[34]LU J, UETZ U, MISKA E A, et al. MicroRNA expression profiles classify human cancers[J]. Nature, 2005, 435 (7043): 834.
[35]WANG C J, ZHOU Z C, WANG I, et al. Clinicopathological significance of microRNA-31, -143 and -145 expression in colorectal cancer[J]. Dis Markers, 2009, 26(1): 27.
[36]XING J, WAN S, ZHOU F, et al. Uenetic polymorphisms in pre-microRNA genes as prognostic markers of colorectal cancer[J]. Cancer Epidemiol Biomarkers Prev, 2012, 21(1): 217.
[37]LU Z, LIU M, STRIBINSKIS V, et al. MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene [J]. Oncogene, 2008, 27(31): 4373.
[38]LIU M, TANG Q, QIU M, et al. miR-21 targets the tumor suppressor Rhob and regulates proliferation, invasion and apoptosis in colorectal cancer cells[J]. FEES Lett, 2011, 585(19): 2998.
[39]MENG F, HENSON R, WEHBE-JANEK H, et al. MicroRNA-21 regulater expression of the PTEN tumor suppressor gene in human hepatocellular cancer[J]. Uastroenterology, 2007, 133(2); 647.
[40]WANG P, ZOU F, ZHANG X, et al. microRNA-21 negatively regulater Cdc25A and cell cycle progression in colon cancer cells[J]. Cancer Res, 2009, 69(20): 8157.
[41]ZhU S, SI M I, WU H, et al. MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1) [J]. J Biol Chem, 2007, 282(19): 14328.
[42]SUN B, UU X, CHEN Z, et al. MiR-610 inhibits cell proliferation and invasion in colorectal cancer by repressing hepatoma-derived growth Iactor[J]. Am J Cancer Res, 2015, 5(12): 3635.
[43]XU R S, WU X D, ZhANG S Q, et al. The tumor suppressor gene RhoBTB1; 、a novel target of miR-31 in human colon cancer[J]. Int J Oncol, 2013, 42(2): 676.
[44]WU J, WU G, LV I, et al. MicroRNA-34a inhibits migration and invasion of colon cancer cells via targeting to Fra-1[J]. Carcinogenesis, 2012, 33(3): 519.
[45]AKAO Y, NOGUCHI S, IIO A, et al. Dysregulation of microRNA-34a expression causes drugresistance to 5-FU in human colon cancer DLD-1 cells[J]. Cancer Lett, 2011, 300(2): 197.
[46]SCHETTER A J, LEUNG S Y, SOHN J J, et al. MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma[J]. JAMA, 2008, 299(4): 42.
[47]VALERI N, UASPARINI P, BRACONI C, et al. MicroRNA-21 induces resistance to lluorouracil by down-regulating human DNA MutS homolog 2 (hMSH2)[J]. Proc Natl Acad Sci U S A, 2010, 107 (49): 21098.
[48]PARDINI B, ROSA F, BARONE E, et al. Variation within 3’-UTRs of base excision repair genes and response to therapy in colorectal cancer patients; A potential modulation of microRNAs binding[J]. Clin Cancer Res, 2013, 19(21): 6044.
[49]SCHEPELER T, REINERT J T, OSTENLELD M S, et al. Diagnostic and prognostic microRNAs in stage II colon cancer[J]. Cancer Res, 2008, 68 (6): 6416.
[50]AKCAKAYA P, EKELUND S, KOLOSENKO I, et al. miR-18 and miR133b deregulation is associated with overall survival and metastaxis in colorectal cancer[J]. Int J Onco1, 2011, 39(2): 311.
[51]BOVELL L C, SHANMUGAM C, PUTCHA B D, et al. The prognostic value of microRNAs varies with patient race/ethnicity and stage of colorectal cancer[J]. Clin Cancer Res, 2013, 19(14): 39.
[52]FARHANA L, ANTAKI F, ANEES M R, et al. Role of cancer stem cells in racial disparity in colorectal cancer[J]. Cancer Med, 2016, 69 (18): 5315.